WHO ICTRP trial

The role of procalcitonin in sepsis

IRCT201102065774N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT201102065774N1
Public title The role of procalcitonin in sepsis
Scientific title Efficacy of procalcitonin level measurement in diagnosis of early antimicrobial resistance in patient with sepsis in emergency department
Primary sponsor vice-chancellor for research of Shahid Beheshti University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 2-3
Countries Iran (Islamic Republic of)
Conditions Condition 1: Sepsis. Condition 2: procalcitonin. Sequelae of infectious and parasitic diseases Abnormal findings on examination of blood, without diagnosis;B90-B94;R70-R79;Sequelae of infectious and parasitic diseases;Abnormal findings on…
Interventions Immunoluminoassy of serum procalcitonin in patient with sepsis, Blood sampling, Lumbar puncture.;Diagnosis;Immunoluminoassy of serum procalcitonin in patient with sepsis, Blood sampling, Lumbar puncture
Registration date Jul 24, 2011
Target size 150
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations